4//SEC Filing
Forte Steve 4
Accession 0001209191-23-006061
CIK 0001808158other
Filed
Jan 31, 7:00 PM ET
Accepted
Feb 1, 9:44 PM ET
Size
7.7 KB
Accession
0001209191-23-006061
Insider Transaction Report
Form 4
Forte Steve
EVP, CHIEF FINANCIAL OFFICER
Transactions
- Award
Employee Stock Option (right to buy)
2023-01-30+111,050→ 111,050 totalExercise: $12.42Exp: 2033-01-29→ Common Shares (111,050 underlying) - Award
Common Shares
2023-01-30+24,530→ 30,687 total
Footnotes (3)
- [F1]Represents a restricted stock unit ("RSU") award. Thirty-three and one third percent (33 1/3%) of the RSUs shall vest on each of January 30, 2024, January 30, 2025 and January 30, 2026, subject to Reporting Person continuing to provide service through each such date.
- [F2]Includes 428 shares and 729 shares acquired on August 13, 2021 and February 15, 2022, respectively, under the Issuer's employee stock purchase plan.
- [F3]Twenty-five percent (25%) of the shares subject to the option shall vest on January 30, 2024, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.
Documents
Issuer
Repare Therapeutics Inc.
CIK 0001808158
Entity typeother
Related Parties
1- filerCIK 0001815428
Filing Metadata
- Form type
- 4
- Filed
- Jan 31, 7:00 PM ET
- Accepted
- Feb 1, 9:44 PM ET
- Size
- 7.7 KB